quoted South Park in a talk
|
|
- Olivia Potter
- 5 years ago
- Views:
Transcription
1 So Many Drugs: Using the Updated Beers' List to Address Polypharmacy MONA Annual Meeting April 22, 2016 Just so I can tell my Teenage Boy I quoted South Park in a talk 1
2 Objectives: To discuss the potential dangers of polypharmacy To present a framework for approaching the patient with polypharmacy To highlight the Beers criteria as a way to analyze potentially inappropriate medications in the older adult 2
3 JUST IN CASE I NEED TO MAKE THE CASE FOR: SO MANY DRUGS. 3
4 4
5 What about the polyspecialist 3 drugs per specialist 4 specialists How many drugs? Sixteen meds 5
6 Sixteen meds 4 specialists x 3 drugs per specialist = 12 Sixteen meds 4 specialists x 3 drugs per specialist = 12????? Can t You do math Tatum????? 6
7 Sixteen meds 4 specialists x 3 drugs per specialist = meds from the ER to treat the med side effects Sixteen meds 4 specialists x 3 drugs per specialist = meds from the ER to treat the med side effects 16 7
8 WHY THIS REALLY MATTERS 8
9 Adverse Drug Effects (ADEs) Incidence of ADEs in hospitals: 26/1000 beds (2.6%) ADEs occur in 35% of community dwelling older adults ADEs are responsible for 5% to 28% of acute geriatric hospital admissions MEDICATIONS MOST COMMONLY INVOLVED IN ADEs Cardiovascular drugs, diuretics, NSAIDs, hypoglycemics, antipsychotics, and anticoagulants Medications with a narrow margin of safety (synthroid, phenytoin, lithium, valproic acid, aminoglycosides, anticoagulants, digoxin, hypoglycemic agents, etc) opioids/benzodiazepines Geriatrics Review Syllabus, Pharmacotherapy, Semla et al Adverse Drug Events After Hospital Discharge in Older Adults: Types, Severity, and Involvement of Beers Criteria Medications J Am Geriatr Soc. 2013; 61:
10 RISK FACTORS FOR ADEs Age 85 or older Female Low body weight or low BMI Estimated CrCl < 50 ml/min 5 9 or more medications 12 or more doses of drugs/day 6 or more concurrent chronic conditions Prior adverse drug event ADE PRESCRIBING CASCADE Drug 1 Adverse drug effect - misinterpreted as a new medical condition Drug 2 Adverse drug effect misinterpreted as a new medical condition 10
11 And some other potential harms of polypharmacy (in case you aren t convinced?) Interactions and increased harm End of life issues Care transitions and readmissions Did you know that in the SNF: Monthly QI measure for polypharmacy has merit 9 or more medications 2.33 times more likely to have an Adverse Drug Reaction (p<0.001) Nguyen, Fouts, Kotabe, Lo. Am J of Geri. Pharmacotherapy
12 End of life is an opportunity for MORE polypharmacy Secondary analysis of a Large Randomized controlled trial of health service delivery in palliative care 460 patients Palliative Care led to: Increase in the number of meds Few reductions in medications Absolute number of medications in this study did not peak until week before death. Currow, Stevenson, Abernathy, et. al. JAGS 2007 The IMPACT of meds on care transitions? Nearly 1/5 Medicare patients discharged from hospital readmitted within 30 days. Readmissions affect 2.6 million patients at a cost of $26 billion every year 12
13 Approximately 20% of persons discharged from hospital to home have an adverse event. Two-thirds of these were because of inappropriate drugs being taken on returning home. (Forster AJ, Murff HJ, Peterson JF, et al 2003) characteristics of adverse drug events after hospital discharge in the elderly Nearly 20% of elderly patients discharged back to the community had at least one adverse drug event (ADE) 1/3 were preventable only 16% involved medications on the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults Kanaan AO, Donovan JL, Duchin NP, J Am Geriatr Soc
14 And the cost? Medicare reimbursement penalties part of the ACA s effort to save costs and improve care by reducing the number of patients who check back into a hospital after treatment. The 2,610 penalized hospitals will lose a total of $428 million in payments 2014 The number of readmitted Medicare patients, or about 2 million people, cost the Federal government about $26 billion each year. How do we track medications as the cause of Readmissions??? 14
15 Successful Post Discharge Calls (Non ED (Inpatient/Observation) vs. ED) Goal Non ED ED 100% 81% 81% 80% 75% 66% 60% 54% 52% 50% 33% 25% 15% 6% 2% 1% 0% '10 '11 Q1 (N=5223; 9922) '10 '11 Q2 (N=4751; 9257) '10 '11 Q3 (N=4678; 8436) '10 '11 Q4 (N=4827; 7811) Discharge Quarter (Denominators Non ED; ED) '11 '12 Q1 (N=4724; 8245) '11 '12 Q2 (N=4653; 7278) 300 Reasons for Follow up September 2010 December 2011 N = 731 Patients Requesting Follow up (938 Area Issues due to multiple areas per patient) Follow up Counts Pre Recent Quarter # of Follow ups
16 All transitions should be accompanied by a legible list of medications and dosages and the indication for the medicine. This simple strategy of a medication list is one of the most powerful tools to decrease errors during transitions. (LaMantia MA, Scheunemann LP, Viera AJ, et al. 2010) Don t be shy, give less meds a try! Why don t we reduce medications on our patients?? And what is a framework to do it? 16
17 A case 88 yo new patient CC dizzy HPI: frequent falls, no vertigo, no clear orthostasis, no cva hx or sx no vision changes, no hearing changes DM2 with neuropathy, Lichen simplex chronicans, DJD knee, Complete rotator tears Lasix 20 mg daily Levo thyroxine 50 µg daily Lyrica 75 mg 1 tablet AM 2 tablets at night Cymbalta 60 mg daily Januvia OCCUvite daily Zyrtec daily Betamethasone 1% cream Ambien 5 mg at night Amlodipine 5 mg Aciphex when necessary GERD KCL 17
18 Step 1: Chief complaint: A case 83 yo new patient CC dizzy HPI: frequent falls, no vertigo, no clear orthostasis, no cva hx or sx no vision changes, no hearing changes 18
19 Lasix 20 mg daily Levo thyroxine 50 µg daily Lyrica 75 mg 1 tablet AM 2 tablets at night Cymbalta 60 mg daily Januvia OCCUvite daily Zyrtec daily Betamethasone 1% cream Ambien 5 mg at night Amlodipine 5 mg Aciphex when necessary GERD KCL Lasix 20 mg daily Levo thyroxine 50 µg daily Lyrica 75 mg 1 tablet AM 2 tablets at night Cymbalta 60 mg daily Januvia OCCUvite daily Zyrtec daily Betamethasone 1% cream Ambien 5 mg at night Amlodipine 5 mg Aciphex when necessary GERD KCL 19
20 Step 1: Chief complaint: Assume the CC is associated with the med list Go to med list and ask which meds cause the cc Step 2 Screen 20
21 Step 2 Screen Annual NH review Annual wellness Are you taking too many meds? Which ones do you think we can get off of? Would you like my advice about reducing meds? Step 3 What is the indication for the medication? 21
22 Another case 89 yo DM2, Severe AS with CHF sp TARP, improving, hx gastroparesis mild, Major depression severe, in remission. DJD. Afib with anticoagulation. CC: nausea Good performance status. Mild cog impairment 22
23 Step 4: Eliminate duplicate medications where able? Step 5: Assess for inappropriate medications BEERS lists Disease specific drug issues INTERACTIONS!!! 23
24 Step 6: special attention to the high risk medications A framework for medication reduction Analyze risks and benefits Stop medications for prevention when no longer able to help (coumadin/aspirin/plavix, statins for prevention, vitamins, etc) Stop medications that have more potential for harm now or less benefit (cholinesterase inhibitors in non ambulatory dementia, alpha blocker in male with catheter) 24
25 Stop when medication didn t have the intended response Medication Appropriateness Index Is there an indication for the drug? Is the medication effective for the condition? Is the dosage correct? Are the directions correct? Are the directions practical? Are there clinically significant drug drug interactions? Are there clinically significant drug disease interactions? Is there unnecessary duplication with other drugs? Is the duration of therapy acceptable? Is this the least expensive alternative? 25
26 NO TEARS Need and indication Open questions Tests and monitoring Evidence and guidelines Adverse events Risk reduction or prevention Simplification and switches Beer s list 26
27 So what are Beer s list meds? An expert panel A list of meds that should Potentially be avoided 27
28 28
29 29
30 DRUG DISEASE OR DRUG SYNDROME INTERACTIONS 30
31 31
32 32
33 33
34 34
35 Total anticholinergic load Lots of medications have anticholinergic impact but not recognized Patient with high anticholinergic load: Diminished performance status by 15% Reduction in global quality of life Increased difficulty concentrating Preventing polypharmacy 35
36 Rationale Polypharmacy Decisions at end of life are Goal Driven Is the goal of the patient (or surrogate) Life prolonging? (and is that consistent with prognosis?) prevention meds still appropriate Functional? Continue medications that help maintain the primary functions of life the patient enjoys Comfort? Stop medications that are not specifically relieving a symptom or directly improving quality of life 36
37 Patient characteristics Dying patient Dying, versus unstable, vs. stable what is prognosis? Active vs. Inactive Wt loss and it s impact on meds (insulin) Medication characteristics Change in absorption (dysphagia), volume of distribution (cachexia), metabolism/excretion (worse renal/hepatic function) Is there withdrawal associated with medication 37
There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients
There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients Marilyn N. Bulloch, PharmD, BCPS Assistant Clinical Professor
More informationDeconstructing Polypharmacy. Alan B. Douglass, M.D. Director
Deconstructing Polypharmacy Alan B. Douglass, M.D. Director Recognize this patient? Mrs. Brown- 82 years young Active Medical Problems Hypertension Hyperlipidemia Type 2 Diabetes Peripheral edema Osteoarthritis
More informationMaximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016
Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016 Adverse Drug Events (ADE s) RISK FACTORS FOR Adverse Drug Events (ADEs) 6 or more concurrent chronic conditions 12 or more doses of drugs/day
More informationGeriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center
Geriatric Pharmacology Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Silver Tsunami 2010: 40 million (13%) 2030: 72 million (20%) Baby Boomers (1946-1964)
More informationDeprescribing Unnecessary Medications: A Four-Part Process
Deprescribing Unnecessary Medications: A Four-Part Process Scott Endsley, MD Fam Pract Manag. 2018;25(3):28-32. Abstract and Introduction Introduction www.medscape.com Ms. Horatio is a 76-year-old patient
More informationHospital Transition Management. Barbara Wood, BSN, MBA
Hospital Transition Management Barbara Wood, BSN, MBA Director, Embedded Care Management Programs OBJECTIVES Improve health care quality for our patients by streamlining care transitions Reduce avoidable
More informationMOQI. What is MOQI? ! One of seven grants awarded across the country to reduce unnecessary transfers from LTC to hospitals
Aging America: Caring for our Elders MOAPA CONFERENCE JUNE 26, 2017 JOANN FRANKLIN, DNP, GNP-BC, FNP-BC, MHNP, FAANP MOQI ADVANCED PRACTICE RN FRANKLINJB@MISSOURI.EDU What is MOQI?! CMS Initiative to Reduce
More informationPolypharmacy: Guidance for Prescribing in Frail Adults
Polypharmacy: Guidance for Prescribing in Frail Adults Why is reviewing polypharmacy important? Medication is by far the most common form of medical intervention. Four out of five people aged over 75 years
More informationGeriatric Pharmacology
Geriatric Pharmacology Janice Scheufler R.Ph.,PharmD, FASCP Clinical Pharmacist Hospice of the Western Reserve Objectives List three risk factors for adverse drug events in the elderly Discuss two physiological
More information3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services:
Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Christina Pornprasert, PharmD Population Health Clinical Pharmacist Hartford Healthcare Integrated Care Partners Addolorata
More informationInnovative Opportunities for Pharmacists in the Evolving World of Healthcare
Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Christina Pornprasert, PharmD Population Health Clinical Pharmacist Hartford Healthcare Integrated Care Partners Assistant Clinical
More informationEnabling the Transition to Hospice through Effective Palliative Care
Enabling the Transition to Hospice through Effective Palliative Care Amber Jones, M.ED Center to Advance Palliative Care Objectives Identify continuity of care improvements to be realized by enhanced inpatient
More informationMedicines save lives
Optimizing Aging Collaborative Disclosures Too much of a good thing: No financial interests to disclose John Newman, MD, PhD Assistant Professor Division of Geriatrics, UCSF Kirby Lee, PharmD, MAS Associate
More informationFrom medicines reconciliation to medicines review. Dr. Fatma Karapinar Hospital pharmacistepidemiologist
From medicines reconciliation to medicines review Dr. Fatma Karapinar Hospital pharmacistepidemiologist Conflict of interest Nothing to disclose Questions Medication review is more important than medicines
More informationObjectives. End-of-Life Exercise. Palliative Care Can Help Patients and Decrease 30-Day Hospital Readmissions.
Palliative Care Can Help Patients and Decrease 30-Day Hospital Readmissions. Objectives Describe how palliative care meets the needs of the patient and family. Discuss how out-patient palliative care can
More informationPHARMACOTHERAPY IN THE OLDER PERSON NAMIRAH JAMSHED M.B;B.S ASSOCIATE PROFESSOR UTSW MEDICAL CENTER DALLAS
1 PHARMACOTHERAPY IN THE OLDER PERSON NAMIRAH JAMSHED M.B;B.S ASSOCIATE PROFESSOR UTSW MEDICAL CENTER DALLAS OBJECTIVES 2 Know and understand: Key issues in geriatric pharmacology Effects of age on pharmacokinetics
More informationDiabetes and the Elderly: Medication Considerations When Determining Benefits and Risks
Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks Gretchen M. Ray, PharmD, PhC, BCACP, CDE Associate Professor UNM College of Pharmacy September 7 th, 2018 DISCLOSURES
More informationRebecca Rottman-Sagebiel, Pharm.D., BCPS Sharon Jung Tschirhart, Pharm.D., BCPS Geriatric Clinical Pharmacy Specialists STVHCS, Audie L.
Rebecca Rottman-Sagebiel, Pharm.D., BCPS Sharon Jung Tschirhart, Pharm.D., BCPS Geriatric Clinical Pharmacy Specialists STVHCS, Audie L. Murphy Division Clinical Assistant Professors, University of Texas/UTHSCSA
More informationCHAPTER 2. GERIATRICS, SELF-ASSESSMENT QUESTIONS
CHAPTER 2. GERIATRICS, SELF-ASSESSMENT QUESTIONS 1. The following is an accurate description of the aging population: A. The number of older adults will reach 17 million in 2030 B. The ratio of women to
More informationLike others here today, we are very conflicted on the FDA s proposal on behind-thecounter medications, but thank you for raising the issue.
Statement of Consumers Union William Vaughan, Senior Policy Analyst before the US Food and Drug Administration Public Meeting on Behind the Counter Availability of Drugs November 14, 2007 Consumers Union
More informationPolypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics
Polypharmacy Kenneth Schmader, MD Professor of Medicine-Geriatrics Polypharmacy Definition Causes Consequences Prevention/management Suboptimal Prescribing in Older Adults Overuse Polypharmacy Underuse
More informationPalliative Care for Older Adults in the United States
Palliative Care for Older Adults in the United States Nathan Goldstein, MD Associate Professor Hertzberg Palliative Care Institute Brookdale Department of Geriatrics and Palliative Medicine Icahn School
More informationSAFETY CONCERNS WITH MULTIPLE MEDICATIONS AND BEYOND. Sandra Brownstein, PharmD, CGP
SAFETY CONCERNS WITH MULTIPLE MEDICATIONS AND BEYOND Sandra Brownstein, PharmD, CGP Objectives: List potential medication related problems that increase in the frail elderly with acute illness Differentiate
More informationHospice and Palliative Care An Essential Component of the Aging Services Network
Hospice and Palliative Care An Essential Component of the Aging Services Network Howard Tuch, MD, MS American Academy of Hospice and Palliative Medicine Physician Advocate, American Academy of Hospice
More informationGERIATRICS 101. Victoria L. Braund, MD, FACP, CMD. Director, Division of Geriatrics, NorthShore Medical Director, Symphony of Evanston
GERIATRICS 101 Victoria L. Braund, MD, FACP, CMD Director, Division of Geriatrics, NorthShore Medical Director, Symphony of Evanston LET S REVIEW Medicare Hospice Pain mgmt. Bowel business Delirium Sleep
More informationPOLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE
POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE Jeannie Kim Lee, PharmD, BCPS, CGP Clinical Pharmacy Director College of Pharmacy The University of Arizona Learning Objectives: State the risks of
More informationStrategies to Decrease Medication Errors in Elderly. Abeer Zeitoun, Pharm. D Certified in Medication Safety, MCPHS
Strategies to Decrease Medication Errors in Elderly Abeer Zeitoun, Pharm. D Certified in Medication Safety, MCPHS Road Map..Outline 1. Introduction A. Definitions B. Geriatrics: High risk population C.
More informationOBJECTIVES. Key issues in geriatric pharmacology. Effects of age on pharmacokinetics and pharmacodynamics
PHARMACOTHERAPY 1 OBJECTIVES 2 Know and understand: Key issues in geriatric pharmacology Effects of age on pharmacokinetics and pharmacodynamics Risk factors for adverse drug events for older patients
More informationTackling inappropriate polypharmacy in NHS Scotland
Tackling inappropriate polypharmacy in NHS Scotland Francesca Aaen Lead Care Homes Pharmacist - NHS Lanarkshire Heather Harrison - Senior Prescribing Advisor/ Chronic Pain Primary Care Service Development
More informationPerfect Endings. Home Alone. Senior Estimate. Staying Alive. Medication Madness
Senior Estimate Home Alone Staying Alive Perfect Endings Medication Madness 10 10 10 10 10 20 20 20 20 20 30 30 30 30 30 40 40 40 40 40 50 50 50 50 50 Senior Estimate - 10 Patients who have multiple interacting
More informationHospitalization- Associated Disability
Hospitalization- Associated Disability Deborah Villarreal, MD Assistant Professor Geriatric and Palliative Medicine An Unfortunately Common Scenario Mrs.G 70 y/o BF DM type II, HTN, s/p CVA, OA, OP admitted
More informationAbout ISMP Canada. Analysis Outputs: Safety Bulletins. Less is More: An Introduction to Deprescribing. canada.org
Less is More: An Introduction to Deprescribing Lindsay Yoo, BSc, BScPhm, RPh, CDE, CGP, PharmD Medication Safety Analyst, ISMP Canada About ISMP Canada The Institute for Safe Medication Practices Canada
More informationTaking the harm out of Polypharmacy Step by step. Karen Reid and Claire Stein Lead Integrated Care Pharmacist NHS Lothian
Taking the harm out of Polypharmacy Step by step Karen Reid and Claire Stein Lead Integrated Care Pharmacist NHS Lothian Presentation: Polypharmacy Overview of the 2015 guidelines The Seven Steps Application
More informationRational prescribing in the older adult. Assoc Prof Craig Whitehead
Rational prescribing in the older adult Assoc Prof Craig Whitehead Introduction Physioloical ageing and frailty Medication risks in older adults Drug Burden Anticholinergic and sedative drug burden Cascade
More informationMedication Management. Medications: The Right Balance. Who are we talking about? Geriatric Syndromes 9/19/2016. Older adults are a heterogenous group!
Medication Management Who are we talking about? Older adults are a heterogenous group! Patricia W. Slattum, PharmD, PhD Professor of Pharmacotherapy and Outcomes Science Director, Geriatric Pharmacotherapy
More informationTools for Targeting High Risk Patients in Your Practice. Statement of Disclosure
Tools for Targeting High Risk Patients in Your Practice Joseph Vande Griend, PharmD, BCPS, CGP Assistant Professor, University of Colorado Departments of Clinical Pharmacy and Family Medicine Skaggs School
More informationMeds and Falls: Keep in Step with your Meds
Meds and Falls: Keep in Step with your Meds Donna Bartlett PharmD, CGP, RPh Associate Professor-Pharmacy Practice MCPHS University Clinical Pharmacist-MCPHS University- Pharmacy Outreach Program donna.bartlett@mcphs.edu
More informationPharmacology in the Elderly
Pharmacology in the Elderly James Hardy Geriatrician, Royal North Shore Hospital A recent consultation Aspirin Clopidogrel Warfarin Coloxyl with senna Clearlax Methotrexate Paracetamol Pantoprazole Cholecalciferol
More informationSpecialist palliative care for patients with heart failure. Dr Katie Taylor Consultant in Palliative Medicine
Specialist palliative care for patients with heart failure Dr Katie Taylor Consultant in Palliative Medicine Objectives Identify which patients to refer to hospice Review symptom management Think about
More informationROAD TO UNDERSTANDING POLYPHARMACY. Lt Col PHIL L. SAMPLES BS Phr, Pharm. D., BCNSP
ROAD TO UNDERSTANDING POLYPHARMACY Lt Col PHIL L. SAMPLES BS Phr, Pharm. D., BCNSP Definition occurs when: 1. a medical regimen includes at least one unnecessary medication 2. Medications have not been
More information9/18/2018. Reforming Care Beyond Healthcare: Opportunities & Challenges for True Palliative Care. Perspectives
Midwest Conference on Palliative & End of Life Care Palliative Care Pre-Conference Kansas City, Missouri October 2018 Reforming Care Beyond Healthcare: Opportunities & Challenges for True Palliative Care
More informationLet it go! Rationalising medicines for patients with life limiting illness
Let it go! Rationalising medicines for patients with life limiting illness Inga Andrew Senior Clinical Pharmacist Northumbria Healthcare Trust E-mail: inga_andrew@northumbria-healthcare.nhs.uk Welcome
More informationAging and Geriatric Assessment March 31, 2008 Sharon Leigh, Pharm D. BCPS Providence ElderPlace
Aging and Geriatric Assessment Page 1 Aging and Geriatric Assessment March 31, 2008 Sharon Leigh, Pharm D. BCPS Providence ElderPlace I. Aging A. Demographics Age 65+ population 3.1 million 1900 31.2 million
More informationAcute Care for Elders- Improving the Quality and Safety of Older Hospitalized Patients
Acute Care for Elders- Improving the Quality and Safety of Older Hospitalized Patients Michael L. Malone, M.D. Aurora Health Care University of Wisconsin School of Medicine and Public Health January 14,
More informationOBJECTIVES: 3/13/2017 HISTORY OF HEALTH CARE FOR THE AGED
OBJECTIVES: Describe the history of care for the aged Describe the current status of health care use by older Americans Discuss current status of the HC workforce Discuss the key principles of health care
More informationEvolutions in Geriatric Fracture Care Preparing for the Silver Tsunami
Evolutions in Geriatric Fracture Care Preparing for the Silver Tsunami James Holstine, DO Medical Director for the Joint Replacement Center, Geriatric Fracture Center, Orthopedic Surgeon PeaceHealth Whatcom
More informationReduction of High Risk Medications Using A Quality Initiative Perspective
Reduction of High Risk Medications Using A Quality Initiative Perspective Richard Mueller PharmD, MBA, MS, Director of Pharmacy Dianne Hempel BSN, RN Quality Improvement Coordinator Objectives Learn what
More informationPotential Drug Dosing Variability in Women. Jim Beaulieu, PharmD Senior Clinical Pharmacist Specialist Rhode Island Hospital and The Miriam Hospital
Potential Drug Dosing Variability in Women Jim Beaulieu, PharmD Senior Clinical Pharmacist Specialist Rhode Island Hospital and The Miriam Hospital 2 Objectives Understand the pharmacokinetic variability
More informationPalliative Care under a Value Based Reimbursement Model. Janet Bull MD, MBA, FAAHPM CMO Four Seasons
Palliative Care under a Value Based Reimbursement Model Janet Bull MD, MBA, FAAHPM CMO Four Seasons Objectives o Describe palliative care o Discuss benefits of palliative care o Understand differences
More informationQUALITY IMPROVEMENT Section 9
Quality Improvement Program The Plan s Quality Improvement Program serves to improve the health of its members through emphasis on health maintenance, education, diagnostic testing and treatment. The Quality
More informationFall Prevention- Staying Vertical. Cindy Rankin, PT Professional Therapy Services, Inc.
Fall Prevention- Staying Vertical Cindy Rankin, PT Professional Therapy Services, Inc. FALLS and the Elderly STAGGERING STATISTICS 30-50% community living elderly over 65 yrs old fall EVERY year (Hornbrook,
More informationPCNE 3rd Medication Review Workshop 1
PCNE 3rd Medication Review Workshop 1 Leuven, 29th May 2012 Facilitators: Foppe van Mil, Pharmacy Practice Consultant, Zuidlaren, The Netherlands Charlotte Rossing, Head of Research & Development, Pharmakon,
More informationAffordability AMGA - MIPS Webinar
Affordability AMGA - MIPS Webinar Beth Averbeck, MD Senior Medical Director Primary Care, HealthPartners Consumer-governed, non-profit HealthPartners Medical Group Primary Care: 500,000 patients 29 locations
More informationStronger together - optimizing pharmacotherapy on geriatric wards?
Stronger together - optimizing pharmacotherapy on geriatric wards? Clinicamp FOD 27/4/2018 Dr. Jean-Claude Lemper ( Geriater UZ Brussel) Apr. Julie Hias (ziekenhuisapotheker UZ Leuven) Project College
More informationFrom Channeling to GRACE: Approaching Reduction in Readmissions and Adverse Drug Events
From Channeling to GRACE: Approaching Reduction in Readmissions and Adverse Drug Events Michael Wasserman, MD, CMD Executive Director, Care Continuum Health Services Advisory Group September 15, 2016 Quality
More informationMedication Use in Older Adults
Medication Use in Older Adults F. Michael Gloth, III, MD, AGSF, FACP, CMD Clinical Professor Department of Geriatrics, Florida State University College of Medicine Associate Professor of Medicine Division
More informationChoosing Wisely Campaign. Lynn McNicoll, MD Alpert Medical School of Brown University Division of Geriatrics and Palliative Medicine
Choosing Wisely Campaign Lynn McNicoll, MD Alpert Medical School of Brown University Division of Geriatrics and Palliative Medicine Disclosures None Purpose of Campaign 5 items (tests, medications, procedures)
More informationFINANCES OF PALLIATIVE CARE
FINANCES OF PALLIATIVE CARE Andrew Molosky, MBA Vice President of Operations Seasons Hospice & Palliative Care Learning Objectives: Distinguish and identify the unique needs of one's organization as it
More informationGreat Low Cost in SNF-NF Jabbar Fazeli, MD Maine Medical Directors Association
Great Care @ Low Cost in SNF-NF Jabbar Fazeli, MD Maine Medical Directors Association Principles Best interest of the patient (SNF) and resident (NF) comes first. Lowest cost to achieve the same care.
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adverse drug events, polypharmacy and perioperative considerations in elderly patients, 377 389 Age, and risk of postoperative urinary retention,
More informationA17/B17: Delirium Can Be Deadly: Save Lives With a Standardized Approach to Delirium IHI 25th Annual National Forum, December 10, 2013
A17/B17: Delirium Can Be Deadly: Save Lives With a Standardized Approach to Delirium IHI 25th Annual National Forum, December 10, 2013 Clay Angel, MD, Hospital Medicine; Chief of Continuum/SNF Kristen
More informationUpdate in Geriatrics: Choosing Wisely Primum Non Nocere
Joseph G. Ouslander, M.D. Professor of Clinical Biomedical Science Senior Associate Dean for Geriatric Programs Chair, Department of Integrated Medical Science Charles E. Schmidt College of Medicine Professor
More informationSTOPP and START criteria October 2011
# START and STOPP are newer criteria to identify potentially inappropriate medications in elderly, including drug drug and drug disease interactions, drugs which increase risk of falls and drugs which
More informationReview of Current Literature 4/2/18 POLYPHARMACY IN ASSISTED LIVING EVIDENCE BASED APPROACH
POLYPHARMACY IN ASSISTED LIVING A Evidence Based Approach to Management of Medication Regimen Complexity By Burton Korer, MSN, RN-BC, CPHQ EVIDENCE BASED APPROACH Evidence-based practice (EBP) is the conscientious
More informationMedications Contributing to Falls. Kate Niemann, PharmD BCGP AuBurn Pharmacy
Medications Contributing to Falls Kate Niemann, PharmD BCGP AuBurn Pharmacy Why Are Falls Important? Leading cause of injury in elders Costs to the system (CDC, 2008) ER Visits: 2.2 million $28.2 billion
More informationDeprescribing in CKD patients: Is less more? Speaker: Dr. Judith G. Marin, PharmD
2016 Deprescribing in CKD patients: Is less more? Speaker: Dr. Judith G. Marin, PharmD Case Mr. Kid Ney is a 75 y/o patient who has been on dialysis for the last 4 years (PD, then HD). PMHx: HTN, DM,
More information2/11/2016. Managing Polypharmacy: Evidence-based Dissection of Pharmaceuticals. Disclosure. Objectives
Managing Polypharmacy: Evidence-based Dissection of Pharmaceuticals Heather Veeder MD Medical Director VITAS Healthcare San Antonio, TX Adjunct Professor of Medicine University of Texas Health Science
More informationWellness along the Cancer Journey: Palliative Care Revised October 2015
Wellness along the Cancer Journey: Palliative Care Revised October 2015 Chapter 3: Addressing Cancer Pain as a part of Palliative Care Palliative Care Rev. 10.8.15 Page 360 Addressing Cancer Pain as Part
More informationMedication Assessment and Quality Parameters. Norma J. Owens, PharmD, FCCP Professor of Pharmacy University of Rhode Island
Medication Assessment and Quality Parameters Norma J. Owens, PharmD, FCCP Professor of Pharmacy University of Rhode Island Financial Disclosure None of the planners, speakers, and/or members of the CME
More informationAssessment that Counts
Assessment that Counts Suzanne Beyea, RN, PhD, FAAN Justin Montgomery RN-BC Dartmouth-Hitchcock Medical Center & Northern New England Geriatric Education Center Objective Operationalize previously known
More informationGS-C SAMPLE QUESTIONS. The correct answer, blueprint area, and rationale for each question appear at the end of the ten questions.
GS-C SAMPLE QUESTIONS The correct answer, blueprint area, and rationale for each question appear at the end of the ten questions. 1. The APRN is working in the emergency department where a critically ill
More informationKetorolac injection. Supportive care
Supportive care Ketorolac injection Supportive care: specialist medicines This leaflet provides information on a medicine called ketorolac which is used to treat pain that is difficult to control. It is
More informationCoordinated End-of-Life Care Improves Wellbeing and Produces Cost Savings POLICY BRIEF: Lydia Ogden, MA, MPP and Kenneth Thorpe, PhD
CENTER FOR ENTITLEMENT REFORM POLICY BRIEF: Coordinated End-of-Life Care Improves Wellbeing and Produces Cost Savings Lydia Ogden, MA, MPP and Kenneth Thorpe, PhD SEPTEMBER 2009 Most Americans are seriously,
More informationPolypharmacy & De-prescribing In Older Adults
Polypharmacy & De-prescribing In Older Adults Maryland Association of Osteopathic Physicians Annual Meeting September 15, 2018 Elizabeth Phung, DO Lead Clinical Associate Physician Beacham Center for Geriatric
More informationClips with Interviews 10/29/2013. What is a Biomarker, and what role do Biomarkers play in modern medicine?
What is a Biomarker, and what role do Biomarkers play in modern medicine? Arnold O. Beckman 30 th Conference November 5, 2013 Robert H. Christenson, Ph.D., DABCC, FACB 2013 AACC President University of
More informationHEART FAILURE QUALITY IMPROVEMENT. American Heart Association Shawni Smith Regional Director, Quality & Systems Improvement
HEART FAILURE QUALITY IMPROVEMENT American Heart Association Shawni Smith Regional Director, Quality & Systems Improvement 1 DISCLOSURES NONE 2 3 WHY IS THIS IMPORTANT? WHY? Heart Failure Currently, an
More informationSubmission on the Draft National Clinical Practice Guidelines for Dementia in Australia
Submission on the Draft National Clinical Practice Guidelines for Dementia in Australia 4 June 2015 details Name of organisation Royal Australian College of General Practitioners () Postal Address Legal
More informationObjectives. What are the Beers Criteria? Mark H Beers, MD Beers Criteria: History and Utilization 5/24/2016
@agilis Objectives Understand what the AGS Beer s list is and the methods used for the AGS Beer s Update HOW TO USE THE BEERS CRITERIA IN PERSONS WITH DEMENTIA & IN YOUR HEALTHCARE SYSTEM DONNA FICK, RN,
More informationModule. Module. Managing Other Chronic Conditions. Managing Other Chronic Conditions
Managing Other Chronic Conditions 8 Managing Other Chronic Conditions Taking Control of Heart Failure Important Information Please write down important contact information in the space below. You may also
More informationThornton Natural Healthcare s Better Health News
February, 2011 Volume 6, Issue 2 Special Interest Articles: Magnesium and CHF Insulin insensitivity and sleep Congestive heart failure CoQ 10, carnitine and CHF Arginine and congestive heart failure Hawthorn
More informationThe Challenge. Bill Frist, M.D.!
The Challenge 5% of U.S. Population Spend 50% of Healthcare Dollars % of Healthcare Spending % of U.S. Population 5% of Medicare beneficiaries die each year accounting for 27.4% of Medicare expenditures
More informationnicheprogram.org 2016 Annual NICHE Conference Care Across the Continuum 1 Dissemination of Geriatrics Guidelines in the Emergency Department:
Dissemination of Geriatrics Guidelines in the Emergency Department: The Intersection of Geriatric Experts, National Guidelines, and Quality Improvement in 3 Midwestern Hospitals. Aaron Malsch MS, RN, GCNS-BC
More informationSurgery in Frail Elders. Emily Finlayson, MD, MS Department of Surgery University of California, San Francisco September, 2011
Surgery in Frail Elders Emily Finlayson, MD, MS Department of Surgery University of California, San Francisco September, 2011 What we re going to cover Mortality after surgery in the elderly Fact v Fantasy
More informationRaising the Bar: Palliative Care in Nursing Homes. No Disclosures. Learning Objectives 3/27/2017
Raising the Bar: Palliative Care in Nursing Homes Diane E. Meier, MD Director, Center to Advance Palliative Care diane.meier@mssm.edu @dianeemeier www.capc.org www.getpalliativecare.org No Disclosures
More informationYour medicines for heart failure
Your medicines for heart failure This leaflet provides information about some of the medicines that you may be given to manage your heart failure. Always read the leaflet that comes with your medication
More informationPresented by: Ontario s Geriatric Steering Committee
Polypharmacy: A Medication Management Opportunity Chris Fan-Lun, BScPhm, ACPR, CGP Clinical Practice Leader, Dept. of Pharmacy Services Mount Sinai Hospital, Sinai Health system Learning Objectives Provide
More informationIt Happens Even in Type 2! When to Start Thinking Seriously About Hypoglycemia
It Happens Even in Type 2! When to Start Thinking Seriously About Hypoglycemia Jacqueline LaManna, PhD, ANP BC, BC ADM, CDE Holly Divine, PharmD, BCACP, CGP, CDE, FAPhA Disclosures Dr. Jacqueline LaManna
More informationTransforming Care for the Elderly
Transforming Care for the Elderly Session 2: Engaging Pharmacists & Interdisciplinary Care Teams to Improve Prescribing of Antipsychotics & to Reduce Polypharmacy January 11, 2017 3 @cfhi_fcass Welcome
More informationAlex Azar Secretary, Department of Health and Human Services
February 28, 2018 Alex Azar Secretary, Department of Health and Human Services Dear Secretary Azar, On behalf of the Endocrine Society members and leaders, I write to offer our assistance as you lead the
More informationThere Is Something More We Can Do: An Introduction to Hospice and Palliative Care
There Is Something More We Can Do: An Introduction to Hospice and Palliative Care presented to the Washington Patient Safety Coalition July 28, 2010 Hope Wechkin, MD Medical Director Evergreen Hospice
More informationPotential disruption from private exchanges and narrow networks. In 2011, less than 10% of companies used High Performing Networks (narrow networks)
1 3 2 Potential disruption from private exchanges and narrow networks. In 2011, less than 10% of companies used High Performing Networks (narrow networks) and in 2014 estimated to be 40%. By 2018, that
More informationA Primer on Safe Prescribing to the Elderly. Dr. John Puxty
A Primer on Safe Prescribing to the Elderly Dr. John Puxty Learning Objectives Describe an approach to safe prescribing for older patients. Appreciate the significance and causes of Polypharmacy. Identify
More informationThe Future of Cardiac Care: Managing Our Patients Together
The Future of Cardiac Care: Managing Our Patients Together Charles R. Caldwell, MD, FACC Disclosures: iheartdoc,inc. Telemedicine 1 MACRA Medicare Access and CHIP Reauthorization Act of 2015 Repealed the
More informationA Drug-related Problem Risk Assessment Tool (DRP-RAT) for use by home care practical nurses
A Drug-related Problem Risk Assessment Tool (DRP-RAT) for use by home care practical nurses Maarit Dimitrow, PhD (Pharm) University of Helsinki Finland www.helsinki.fi/yliopisto Background The demand for
More information61 Recommendations for better use of medications
Chapter 61 Recommendations for better use of medications As stated elsewhere in this book, we are fortunate to have a number of effective medications for treatment of many medical conditions. The drug
More informationCover images courtesy of jk1991 at FreeDigitalPhotos.net Infographics courtesy of SIMPATHY consortium
If using any content from this document, please acknowledge the Scottish Government Polypharmacy Model of Care Group, 2018. When referencing this document, please use the following format: Scottish Government
More informationChronicity and Aging: The Geriatric Imperative
Chronicity and Aging: The Geriatric Imperative Steven L. Phillips, MD Medical Director Sanford Center for Aging Professor, Clinical Internal Medicine University of Nevada, Reno School of Medicine dhs.unr.edu/aging
More informationKey Findings. Mortality Rates
Mortality Rates Statewide in-hospital mortality rates showed a statistically significant decrease from federal fiscal year to federal fiscal year in 12 of the 15 conditions reported. The largest decrease
More informationWIN-WIN-WIN APPROACHES TO ACCOUNTABLE CARE How Better Payment for Hospice and Palliative Care Can Benefit Providers, Patients, and Payers
WIN-WIN-WIN APPROACHES TO ACCOUNTABLE CARE How Better Payment for Hospice and Palliative Care Can Benefit Providers, Patients, and Payers Harold D. Miller President and CEO Center for Healthcare Quality
More informationDelirium in the Elderly
Delirium in the Elderly ELITE 2015 Mamata Yanamadala M.B.B.S, MS Division of Geriatrics Why should we care about delirium? It is: common associated with high mortality associated with increased morbidity
More information